EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study

Vural Taner Yılmaz, Erol Demir, Hüseyin Koçak, Ayşe Sinangil, Rahmi Yılmaz, Şebnem Karakan, Rezzan Eren Sadioğlu, Berna Yelken, Ebru Ok, Murathan Uyar, Arzu Velioğlu, Ergün Parmaksız und 5 weitere

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.04.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Vural Taner Yılmaz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology, Akdeniz University Faculty of Medicine, Antalya, Türkiye. Electronic address: vuraltaneryl@y…. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Antilymphocyte Serum, Recombinant Fusion Proteins. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACGROUND: This study aimed to compare the efficacy and safety of induction treatments in kidney transplant recipients. METHODS: A total of 2564 kidney transplant recipients from 15 transplant centers were included in the study and were categorized into 3 groups for comparison. Group 1: No induction (n = 222, 8.7%), Group 2: Anti-T lymphocyte globulin (ATLG, n = 1794, 70%) and Group 3: Basiliximab (n = 548, 21.4%). The results were compared across 3 post-transplant periods: the first month, the 1st to 6th month, and the 6th to 12th month. RESULTS: Prior to propensity score matching (PSM), there were no significant differences in graft/patient survival, BKV (polyomavirus) incidence, or rejection rates during the first month among the groups. However, the Anti-T lymphocyte globulin (ATLG) group exhibited higher rates of developing donor-specific antibodies (DSA), cytomegalovirus (CMV) infection, general infections, and delayed graft function (DGF), along with higher rejection rates at 1 month post-transplant. After the PSM analysis, rejection rates (which were higher in the ATLG group compared to the Basiliximab group only in the first month), graft/patient loss, and BKV rates were comparable. Infection, CMV, and DSA rates remained elevated in the ATLG group. Clinical results of groups 1 and 3 were similar. CONCLUSIONS: This study shown that ATLG provides positive clinical results despite increased infection and DSA formation in patients with high immunological risk, whereas the efficacy and necessity of induction in patients with low-moderate immunological risk is debatable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsAntilymphocyte SerumRecombinant Fusion ProteinsHumansRetrospective StudiesPropensity ScoreMaleFemaleMiddle AgedGraft RejectionBasiliximabAdultGraft SurvivalTreatment OutcomeAntibodies, MonoclonalTime Factors

Substanzen

Immunosuppressive AgentsAntilymphocyte SerumBasiliximabRecombinant Fusion ProteinsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Nephrology, Akdeniz University Faculty of Medicine, Antalya, Türkiye. Electronic address: vuraltaneryl@yahoo.com.tr.
  • Department of Internal Medicine, Division of Nephrology, İstanbul Faculty of Medicine, İstanbul, Türkiye.
  • Department of Internal Medicine, Division of Nephrology, Akdeniz University Faculty of Medicine, Antalya, Türkiye.
  • İstanbul Florence Nighthingale Hospital, Department of Internal Medicine, Division of Nephrology, Demiroğlu Bilim University, İstanbul, Türkiye.
  • Department of Internal Medicine, Division of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of Internal Medicine, Division of Nephrology, Yıldırım Beyazıt University Ankara City Hospital, Ankara, Türkiye.

Zitieren

APA

Yılmaz, V. T., Demir, E., Koçak, H., Sinangil, A., Yılmaz, R., Karakan, Ş., Sadioğlu, R. E., Yelken, B., Ok, E., Uyar, M., Velioğlu, A., Parmaksız, E., Bakır, E. A., Çakır, Ü., Seyahi, N., Dheir, H., & Türkmen, A. (2025). Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.04.003

Vancouver

Yılmaz VT, Demir E, Koçak H, Sinangil A, Yılmaz R, Karakan Ş, et al. Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.04.003

BibTeX
@article{Ylmaz2025,
  author = {Yılmaz, Vural Taner and Demir, Erol and Koçak, Hüseyin and Sinangil, Ayşe and Yılmaz, Rahmi and Karakan, Şebnem and Sadioğlu, Rezzan Eren and Yelken, Berna and Ok, Ebru and Uyar, Murathan and Velioğlu, Arzu and Parmaksız, Ergün and Bakır, Elif Arı and Çakır, Ülkem and Seyahi, Nurhan and Dheir, Hamad and Türkmen, Aydın},
  title = {Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.04.003}
}
Kostenlos starten →